Suppr超能文献

丙型肝炎病毒诱导的miR-181a减少通过双特异性磷酸酶6的过表达损害CD4(+) T细胞反应。

Hepatitis C virus-induced reduction in miR-181a impairs CD4(+) T-cell responses through overexpression of DUSP6.

作者信息

Li Guang Y, Zhou Yun, Ying Ruo S, Shi Lei, Cheng Yong Q, Ren Jun P, Griffin Jeddidiah W D, Jia Zhan S, Li Chuan F, Moorman Jonathan P, Yao Zhi Q

机构信息

Center for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN.

出版信息

Hepatology. 2015 Apr;61(4):1163-73. doi: 10.1002/hep.27634. Epub 2015 Feb 4.

Abstract

UNLABELLED

T cells play a crucial role in viral clearance or persistence; however, the precise mechanisms that control their responses during viral infection remain incompletely understood. MicroRNA (miR) has been implicated as a key regulator controlling diverse biological processes through posttranscriptional repression. Here, we demonstrate that hepatitis C virus (HCV)-mediated decline of miR-181a expression impairs CD4(+) T-cell responses through overexpression of dual specific phosphatase 6 (DUSP6). Specifically, a significant decline of miR-181a expression along with overexpression of DUSP6 was observed in CD4(+) T cells from chronically HCV-infected individuals compared to healthy subjects, and the levels of miR-181a loss were found to be negatively associated with the levels of DUSP6 overexpression in these cells. Importantly, reconstitution of miR-181a or blockade of DUSP6 expression in CD4(+) T cells led to improved T-cell responses including enhanced CD25 and CD69 expression, increased interleukin-2 expression, and improved proliferation of CD4(+) T cells derived from chronically HCV-infected individuals.

CONCLUSION

Since a decline of miR-181a concomitant with DUSP6 overexpression is the signature marker for age-associated T-cell senescence, these findings provide novel mechanistic insights into HCV-mediated premature T-cell aging through miR-181a-regulated DUSP6 signaling and reveal new targets for therapeutic rejuvenation of impaired T-cell responses during chronic viral infection.

摘要

未标记

T细胞在病毒清除或持续存在中起关键作用;然而,病毒感染期间控制其反应的精确机制仍未完全了解。微小RNA(miR)已被认为是通过转录后抑制控制多种生物学过程的关键调节因子。在此,我们证明丙型肝炎病毒(HCV)介导的miR-181a表达下降通过双特异性磷酸酶6(DUSP6)的过表达损害CD4(+) T细胞反应。具体而言,与健康受试者相比,在慢性HCV感染个体的CD4(+) T细胞中观察到miR-181a表达显著下降以及DUSP6过表达,并且发现这些细胞中miR-181a缺失水平与DUSP6过表达水平呈负相关。重要的是,在CD4(+) T细胞中重建miR-181a或阻断DUSP6表达导致T细胞反应改善,包括增强的CD25和CD69表达、增加的白细胞介素-2表达以及慢性HCV感染个体来源的CD4(+) T细胞增殖改善。

结论

由于miR-181a下降与DUSP6过表达同时出现是与年龄相关的T细胞衰老的标志性标志物,这些发现为HCV介导的通过miR-181a调节的DUSP6信号通路导致的T细胞过早衰老提供了新的机制见解,并揭示了慢性病毒感染期间受损T细胞反应治疗性恢复活力的新靶点。

相似文献

引用本文的文献

本文引用的文献

3
Hepatitis C virus and microRNAs: miRed in a host of possibilities.丙型肝炎病毒与微小RNA:众多可能性中的miRed
Curr Opin Virol. 2014 Aug;7:1-10. doi: 10.1016/j.coviro.2014.03.004. Epub 2014 Apr 12.
6
Immune responses to HCV and other hepatitis viruses.对 HCV 和其他肝炎病毒的免疫反应。
Immunity. 2014 Jan 16;40(1):13-24. doi: 10.1016/j.immuni.2013.12.010.
8
Novel therapeutic approaches for hepatitis C.新型丙型肝炎治疗方法。
Clin Pharmacol Ther. 2014 Jan;95(1):78-88. doi: 10.1038/clpt.2013.206. Epub 2013 Oct 14.
9
Emerging concepts in immunity to hepatitis C virus infection.丙型肝炎病毒感染免疫的新观点。
J Clin Invest. 2013 Oct;123(10):4121-30. doi: 10.1172/JCI67714. Epub 2013 Oct 1.
10
Novel therapies for hepatitis C - one pill fits all?新型丙型肝炎治疗方法——一药通用?
Nat Rev Drug Discov. 2013 Aug;12(8):595-610. doi: 10.1038/nrd4050. Epub 2013 Jun 28.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验